Pneumonia, Viral
Information
- Disease name
- Pneumonia, Viral
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04305457 | Active, not recruiting | Phase 2 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 | March 21, 2020 | April 2025 |
| NCT04429555 | Active, not recruiting | Phase 2 | Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS | January 11, 2021 | December 1, 2023 |
| NCT04916834 | Active, not recruiting | Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure. | August 30, 2020 | November 30, 2024 | |
| NCT05805579 | Completed | Diaphragmatic Echography in COVID-19 Pneumonia | February 1, 2021 | June 20, 2021 | |
| NCT04047719 | Completed | Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens | November 5, 2019 | June 6, 2022 | |
| NCT05619640 | Completed | The Potential Role of sRAGE, KL-6, and SP-D as Prognostic Factors in Children With COVID-19 | July 1, 2021 | September 30, 2022 | |
| NCT05321433 | Completed | Tobacco Use and the Risk of COVID-19 and Adverse Outcomes | April 1, 2022 | December 31, 2023 | |
| NCT05279482 | Completed | Comparison Between Different Doses of Steroids in COVID-19 Patients | January 19, 2022 | March 9, 2022 | |
| NCT05279469 | Completed | D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients | June 10, 2021 | March 9, 2022 | |
| NCT04321278 | Completed | Phase 3 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | March 28, 2020 | June 14, 2020 |
| NCT04322487 | Completed | Simple, Safe, Same: Lung Ultrasound for COVID-19 | April 8, 2020 | December 31, 2021 | |
| NCT04322565 | Completed | Phase 2 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | April 20, 2020 | October 1, 2021 |
| NCT04324684 | Completed | Prognostic Factors Keeping Track for COVID-19 Pneumonia | March 31, 2020 | May 7, 2020 | |
| NCT05244356 | Completed | N/A | Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation | April 29, 2021 | June 7, 2021 |
| NCT04330261 | Completed | Clinical Characteristics and Outcomes of Pediatric COVID-19 | March 18, 2020 | April 5, 2022 | |
| NCT05021588 | Completed | N/A | Steroid and Anticoagulant Therapy in covid19 | April 12, 2020 | September 10, 2020 |
| NCT04340466 | Completed | French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study | April 3, 2020 | July 3, 2020 | |
| NCT04341766 | Completed | Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 | March 31, 2020 | June 30, 2020 | |
| NCT04914832 | Completed | Phase 4 | Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death | August 30, 2021 | September 30, 2022 |
| NCT04347031 | Completed | Phase 2/Phase 3 | A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 | April 8, 2020 | November 20, 2020 |
| NCT04878055 | Completed | Phase 3 | Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. | February 14, 2021 | October 31, 2021 |
| NCT04830800 | Completed | Phase 1/Phase 2 | A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC | March 10, 2021 | March 11, 2022 |
| NCT04453501 | Completed | Anti Infective Agents Impact in COVID-19 Pneumonia | March 2, 2020 | April 25, 2020 | |
| NCT01271842 | Completed | Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study | October 2010 | ||
| NCT05808361 | Completed | N/A | Rehabilitation Treatment of Patients With COVID-19 | April 1, 2020 | June 15, 2021 |
| NCT04479540 | Completed | N/A | Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease | May 26, 2020 | March 5, 2022 |
| NCT04476992 | Completed | Phase 1/Phase 2 | Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement | July 24, 2020 | September 17, 2021 |
| NCT04826731 | Completed | Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients | April 1, 2021 | July 1, 2021 | |
| NCT04799132 | Completed | Association Between Body Mass Index and HFNC Therapy Success | March 11, 2020 | March 1, 2021 | |
| NCT04368377 | Completed | Phase 2 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | April 6, 2020 | April 23, 2020 |
| NCT04789447 | Completed | Initial CT Findings and CO-RADS Stage in COVID-19 | March 4, 2021 | May 6, 2021 | |
| NCT04764422 | Completed | Phase 1/Phase 2 | Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand | March 20, 2021 | September 12, 2022 |
| NCT04374071 | Completed | Early Short Course Corticosteroids in COVID-19 | March 12, 2020 | April 30, 2020 | |
| NCT04727775 | Completed | Antiviral Drugs on the Treatment of SARS-CoV-2 | December 1, 2020 | July 25, 2023 | |
| NCT04724538 | Completed | Phase 1/Phase 2 | Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 | October 15, 2020 | March 15, 2021 |
| NCT04723563 | Completed | Phase 4 | Nebulized Heparin for the Treatment of COVID-19 | February 22, 2021 | August 23, 2021 |
| NCT04382547 | Completed | Phase 1/Phase 2 | Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells | May 11, 2020 | June 30, 2021 |
| NCT04384055 | Completed | Predicting Outcomes for Covid-19 Using Sonography | March 21, 2020 | November 15, 2021 | |
| NCT04387799 | Completed | Determinants of COVID-19 Pneumonia (MC-19) | May 13, 2020 | June 17, 2020 | |
| NCT04716556 | Completed | N/A | TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients | July 16, 2020 | May 31, 2021 |
| NCT04629703 | Completed | Phase 3 | Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects | March 25, 2021 | September 5, 2022 |
| NCT04606407 | Completed | N/A | Inhaled NO for the Treatment of Viral Pneumonia in Adults | November 25, 2020 | August 7, 2022 |
| NCT04577105 | Completed | Risk Factors and Computed Tomography Findings in COVID-19. | April 1, 2020 | October 1, 2020 | |
| NCT04570254 | Completed | N/A | Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 | August 19, 2020 | December 1, 2020 |
| NCT04561219 | Completed | Phase 2 | Nitazoxanide Therapy for Patients With COVID-19 Pneumonia | April 19, 2020 | October 2, 2020 |
| NCT04550325 | Completed | Phase 1/Phase 2 | Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 | August 5, 2020 | November 26, 2020 |
| NCT04519385 | Completed | N/A | Toclizumam Versus Dexamethasone in Severe Covid-19 Cases | March 1, 2020 | August 5, 2020 |
| NCT04422613 | Completed | N/A | Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia | May 28, 2020 | October 29, 2021 |
| NCT04517123 | Completed | N/A | Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study | September 1, 2020 | December 31, 2021 |
| NCT04424836 | Completed | HFNC Treatment in COVID-19 Pneumonia | May 15, 2020 | June 5, 2020 | |
| NCT04435327 | Completed | Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) | October 5, 2020 | March 18, 2022 | |
| NCT04358588 | No longer available | Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19 | |||
| NCT04355494 | No longer available | SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19 | |||
| NCT06296693 | Not yet recruiting | N/A | Diagnostic Accuracy of Pocket-size Lung Ultrasound in Pneumonia Etiology and Complications in Hospitalized Children | April 1, 2024 | April 30, 2025 |
| NCT05976581 | Recruiting | N/A | Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients | November 1, 2023 | December 15, 2024 |
| NCT04764929 | Recruiting | N/A | Pediatric Helmet CPAP Pilot Study | August 7, 2021 | September 2022 |
| NCT06134492 | Recruiting | Phase 3 | Acyclovir in Mechanically Ventilated Patients With Pneumonia and HSV-1 in BAL | February 20, 2024 | December 2026 |
| NCT04836780 | Recruiting | Phase 3 | DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia | June 10, 2021 | March 30, 2023 |
| NCT05077917 | Recruiting | Phase 3 | Cromolyn Sodium for Treatment of COVID-19 Pneumonia | November 15, 2021 | December 2024 |
| NCT05123755 | Recruiting | Phase 2 | Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia. | December 20, 2021 | March 2025 |
| NCT04394182 | Suspended | N/A | Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 | April 21, 2020 | March 21, 2022 |
| NCT04264533 | Terminated | Phase 2 | Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia | February 14, 2020 | March 29, 2020 |
| NCT01014364 | Terminated | Phase 3 | Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu | March 2010 | December 2011 |
| NCT04327401 | Terminated | Phase 3 | COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III | April 13, 2020 | July 22, 2020 |
| NCT04344951 | Terminated | Phase 2 | Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial | April 6, 2020 | November 30, 2020 |
| NCT04335305 | Terminated | Phase 2 | Checkpoint Blockade in COVID-19 Pandemic | April 9, 2020 | June 21, 2021 |
| NCT04422691 | Terminated | Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection | July 1, 2020 | June 15, 2021 | |
| NCT04397692 | Terminated | N/A | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) | June 13, 2020 | September 30, 2020 |
| NCT04345861 | Terminated | Phase 2/Phase 3 | Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) | April 11, 2020 | April 9, 2021 |
| NCT04619693 | Terminated | Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia | November 18, 2020 | October 6, 2021 | |
| NCT04369469 | Terminated | Phase 3 | Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia | May 10, 2020 | April 8, 2021 |
| NCT04443673 | Terminated | N/A | Glycine Supplement for Severe COVID-19 | June 15, 2020 | June 14, 2021 |
| NCT04356508 | Unknown status | Phase 2 | COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1 | April 14, 2020 | August 31, 2021 |
| NCT04474340 | Unknown status | Phase 1 | COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients | May 21, 2020 | December 30, 2020 |
| NCT04353141 | Unknown status | International Lung UltraSound Analysis (ILUSA) Study | April 28, 2020 | December 31, 2020 | |
| NCT04834947 | Unknown status | Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19 | April 15, 2021 | December 15, 2021 | |
| NCT04480034 | Unknown status | Obesity Surgery During 2020 Italian Pandemic | July 15, 2020 | May 30, 2021 | |
| NCT04528888 | Unknown status | Phase 3 | Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection | November 25, 2020 | July 30, 2021 |
| NCT04414293 | Unknown status | N/A | Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis | October 1, 2020 | December 31, 2021 |
| NCT04408235 | Unknown status | Phase 3 | High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy | June 2020 | June 2021 |
| NCT04401228 | Unknown status | Predictive Models for Intensive Care Admission and Death of COVID-19 | March 1, 2020 | January 1, 2021 | |
| NCT04399681 | Unknown status | N/A | The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 | May 10, 2020 | September 10, 2020 |
| NCT04627194 | Unknown status | Characteristics of COVID-19 Patients in Kazakhstan in Early 2020 | February 20, 2020 | December 1, 2020 | |
| NCT04388657 | Unknown status | COVID-19, bLOod Coagulation and Thrombosis | May 1, 2020 | September 1, 2020 | |
| NCT04381364 | Unknown status | Phase 2 | Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) | May 29, 2020 | January 31, 2022 |
| NCT04380818 | Unknown status | N/A | Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 | June 5, 2020 | November 1, 2021 |
| NCT04728880 | Unknown status | Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience | January 26, 2021 | May 30, 2021 | |
| NCT04370275 | Unknown status | Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia | April 23, 2020 | May 31, 2020 | |
| NCT04786301 | Unknown status | Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza) | April 30, 2020 | March 2022 | |
| NCT04366089 | Unknown status | Phase 2 | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | March 26, 2020 | December 31, 2020 |
| NCT04824313 | Unknown status | Vascular Abnormalities Detected With Chest CT in COVID-19 | March 1, 2020 | March 31, 2021 | |
| NCT04365101 | Unknown status | Phase 1/Phase 2 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 | May 13, 2020 | June 30, 2022 |
| NCT04826822 | Unknown status | Phase 3 | Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 | February 24, 2021 | September 2, 2021 |
| NCT04313946 | Unknown status | Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays | March 18, 2020 | August 18, 2020 | |
| NCT05290441 | Unknown status | N/A | Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia | August 15, 2021 | March 2022 |
| NCT04269525 | Unknown status | Phase 2 | Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia | February 6, 2020 | December 30, 2020 |
| NCT01747369 | Unknown status | Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013 | April 2010 | June 2017 | |
| NCT01492387 | Unknown status | Phase 4 | Duration of Antibiotic Therapy in Community - Acquired Pneumonia | January 2012 | March 2015 |
| NCT04675086 | Withdrawn | Phase 3 | Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection | January 2021 | December 2021 |
| NCT04381923 | Withdrawn | N/A | COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia | November 15, 2021 | December 15, 2022 |
| NCT04513314 | Withdrawn | Phase 4 | Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium | March 28, 2023 | March 28, 2023 |
| NCT04290858 | Withdrawn | Phase 2 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection | March 1, 2020 | February 1, 2022 |
| NCT04456088 | Withdrawn | Phase 2 | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial) | July 15, 2020 | December 15, 2020 |
| NCT04418531 | Withdrawn | N/A | Convalescent Antibodies Infusion in COVID 19 Patients | June 1, 2020 | September 21, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011024